AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy
Clinical trial NCT03308604 · UNKNOWN
Trial details
- NCT number
- NCT03308604
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2022-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.